top of page
Fast Forward Therapeutic Innovation
Discovery
Preclinical Development
Phase 1
Phase 2
Phase 3
ABI-01: Idiopathic Pulmonary Fibrosis (IPF)
ABI-02: Alzheimer's Disease
ABI-03: liver fibrosis/nonalcoholic steatohepatitis (NASH)
bottom of page